Abstract PD1-08: Oral paclitaxel and encequidar (oPac+E) versus IV paclitaxel (IVPac) in the treatment of metastatic breast cancer (mBC) patients (study KX-ORAX-001): Progression f... von Umanzor, G, Rugo, H S, Barrios, F J, Vasallo, R H, Chivalan, M A, Bejarano, S, Ramirez, J R, Fein, L, Kowalyszyn, R D, Cutler, D L, Kramer, D, Goldfinch, J, Wang, H, Moore, T, Kwan, R MF

Volltext

Abstract PS13-11: Oral paclitaxel and encequidar (oPac+E) in the treatment of metastatic breast cancer (mBC): Management of gastrointestinal adverse events (GI AE). Study KX-ORAX-0... von Rugo, H S, Umanzor, G, Barrios, F J, Vasallo, R H, Chivalan, M A, Bejarano, S, Ramirez, J R, Fein, L, Kowalyszyn, R D, Cutler, D L, Kramer, D, Goldfinch, J, Wang, H, Moore, T, Kwan, R MF

Volltext

Abstract PS13-06: Lower rates of neuropathy with oral paclitaxel and encequidar (oPac+E) compared to IV paclitaxel (IVPac) in treatment of metastatic breast cancer (mBC): Study KX-... von Rugo, H S, Umanzor, G, Barrios, F J, Vasallo, R H, Chivalan, M A, Bejarano, S, Ramirez, J R, Fein, L, Kowalyszyn, R D, Cutler, D L, Kramer, D, Goldfinch, J, Wang, H, Moore, T, Kwan, R MF

Volltext

Abstract P1-16-05: Oraxol + Encequidar (OPac+E) vs IV paclitaxel (IVPac) in the treatment of patients with metastatic breast cancer (mBC) (Study KX-ORAX-001): Subgroup survival ana... von Umanzor, Gerardo, Rugo, Hope S, Barrios, Francisco J, Vasallo, R H, Chivalan, Marco A, Bejarano, S, Ramirez, Julio Roberto, Fein, Luis, Kowalyszyn, R D, Cutler, D L, Kramer, D, Wang, H, Kwan, R MF

Volltext

Confirmed tumor response by molecular subtype in patients with metastatic breast cancer: Sub-analysis from a phase 3 clinical study comparing oral paclitaxel and encequidar to IV p... von Umanzor Funez, Gerardo Antonio, Rugo, Hope S., Umanzor, Jorge, Barrios, Francisco, Vasallo, Rosa, Chivalan, M, Bejarano, Suyapa A., Ramirez, Julio Roberto, Fein, Luis Enrique, Kowalyszyn, Ruben Dario, Wang, Hui, Cutler, David

Volltext

Abstract GS6-01: Oral paclitaxel with encequidar: The first orally administered paclitaxel shown to be superior to IV paclitaxel on confirmed response and survival with less neurop... von Umanzor, Gerardo, Cutler, David L, Barrios, Francisco J, Vassallo, Rosa H, Chivalan, Marco A, Bejarano, Suyapa A, Ramirez, Julio R, Fein, Luis, Kramer, E Douglas, Kowalyszyn, Rubio D, Wang, Hui, Goldfinch, John, Moore, Taryn, Kwan, Rudolf MF

Volltext